Skye Bioscience, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Skye Bioscience, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Skye Bioscience, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.9M, a 84.4% increase year-over-year.
  • Skye Bioscience, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$21.2M, a 50.7% increase year-over-year.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.6M, a 93.2% decline from 2022.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.5M, a 129% decline from 2021.
  • Skye Bioscience, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$8.52M, a 29.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$21.2M -$3.9M +$21M +84.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$42.3M -$7.9M -$4.79M -154% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$37.5M -$5.02M +$148K +2.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$37.6M -$4.42M +$5.47M +55.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$43.1M -$24.9M -$21.8M -698% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$21.3M -$3.11M +$308K +9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$21.6M -$5.17M -$2.12M -69.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$19.5M -$9.89M -$7.38M -294% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$12.1M -$3.13M -$1.3M -71.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$10.8M -$3.42M -$1.4M -68.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$9.41M -$3.04M -$883K -40.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$8.52M -$2.51M -$1.01M -67.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$7.51M -$1.82M -$528K -40.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$6.98M -$2.02M -$604K -42.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$6.38M -$2.16M +$181K +7.74% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$6.56M -$1.5M -$6.35M -131% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$207K -$1.3M +$3.63M +73.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.84M -$1.42M -$17.3M -109% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 $13.5M -$2.34M +$12.4M +84.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 $1.05M $4.85M +$11.1M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$10M -$4.93M -$2.83M -135% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$7.19M $15.9M +$18.6M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 -$25.8M -$14.8M -$6.56M -79.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$19.2M -$6.22M -$5.59M -890% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 -$13.6M -$2.1M -$1.62M -337% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$12M -$2.66M -$1.96M -279% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$10M -$8.21M -$6.93M -540% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$3.09M -$628K +$492K +43.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$3.59M -$480K +$465K +49.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$4.05M -$703K -$1.28M -223% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$2.78M -$1.28M +$402K +23.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$3.18M -$1.12M -$429K -62.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$2.75M -$945K +$238K +20.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$2.99M $573K +$2.63M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$5.62M -$1.69M -$775K -85.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$4.84M -$691K +$1.01M +59.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$5.85M -$1.18M -$324K -37.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$5.53M -$2.06M -$1.91M -1339% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$3.61M -$910K -$880K -2924% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$2.73M -$1.7M -$1.71M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 -$1.03M -$859K -$828K -2752% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$200K -$143K -$142K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$57.3K -$30.1K -$2.1M -101% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $2.04M $3.62K* +$3.46K Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 $2.04M -$30.1K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$712* -$767 May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $2.07M +$2.07M Jan 31, 2013 Apr 30, 2013 10-Q 2014-06-05
Q4 2012 $160* Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q2 2012 $55.00* May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$381* Jan 31, 2012 Apr 30, 2012 10-Q 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.